Glucagon-like
peptide-1 (GLP-1) has been shown to protect pancreatic
β-cells against cytokine-induced dysfunction and destruction.
The mechanisms through which GLP-1 exerts its effects are complex
and still poorly understood. The aim of this study was to analyze
the protein expression profiles of human islets of Langerhans treated
with cytokines (IL-1β and IFN-γ) in the presence or absence
of GLP-1 by 2D difference gel electrophoresis and subsequent protein
interaction network analysis to understand the molecular pathways
involved in GLP-1-mediated β-cell protection. Co-incubation
of cytokine-treated human islets with GLP-1 resulted in a marked protection
of β-cells against cytokine-induced apoptosis and significantly
attenuated cytokine-mediated inhibition of glucose-stimulated insulin
secretion. The cytoprotective effects of GLP-1 coincided with substantial
alterations in the protein expression profile of cytokine-treated
human islets, illustrating a counteracting effect on proteins from
different functional classes such as actin cytoskeleton, chaperones,
metabolic proteins, and islet regenerating proteins. In summary, GLP-1
alters in an integrated manner protein networks in cytokine-exposed
human islets while protecting them against cytokine-mediated cell
death and dysfunction. These data illustrate the beneficial effects
of GLP-1 on human islets under immune attack, leading to a better
understanding of the underlying mechanisms involved, a prerequisite
for improving therapies for diabetic patients.